Opportunity ID: 203035

General Information

Document Type:: Grants Notice
Funding Opportunity Number:: PAR-13-002
Funding Opportunity Title:: NHLBI Clinical Trial Pilot Studies (R34)
Opportunity Category:: Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity:: Health
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s):: 93.233 — National Center on Sleep Disorders Research
Cost Sharing or Matching Requirement:: No
Version:: Synopsis 2
Posted Date:: Oct 02, 2012
Last Updated Date:: Nov 17, 2015
Original Closing Date for Applications:: Jan 07, 2016
Current Closing Date for Applications:: Nov 17, 2015
Archive Date:: Dec 17, 2015
Estimated Total Program Funding::
Award Ceiling:: $225,000
Award Floor:: $

Eligibility

Eligible Applicants:: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility:: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name:: National Institutes of Health
Description:: The National Heart, Lung, and Blood Institute (NHLBI) encourages applications proposing pilot studies to obtain data that is critical for the design of robust clinical trials. This Funding Opportunity Announcement (FOA) should be used to fill gaps in scientific knowledge necessary to develop a competitive full-scale clinical trial. Appropriate pilot studies might demonstrate feasibility of an intervention or an experimental design, estimate intervention parameters, or gather other data important for the design of a trial. Applicants who propose solely to write a protocol or manual of operations or to develop infrastructure for a clinical trial will not be considered appropriate for to this announcement. Applications must demonstrate that the proposed pilot studies are both necessary and sufficient to permit the design of the clinical trial. During the evaluation of applications submitted to this FOA, the review group will also consider the significance and potential public health impact of the full-scale clinical trial that would be proposed following the R34 award period. The NHLBI anticipates that the R34 award period will yield robust investigator-initiated clinical trial grant applications for the evaluation of interventions for the treatment or prevention of heart, lung, blood, or sleep disorders.
Link to Additional Information::
Grantor Contact Information:: If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version Modification Description Updated Date
Synopsis 2 Modified the close date, in accordance with PAR-16-037. Nov 17, 2015
Synopsis 1

Package

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Package No: 2

Packages

Assistance Listings Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions Who Can Apply:
ADOBE-FORMS-B2 Adobe-Forms-B2 PKG00148521 Jan 16, 2013 Sep 24, 2013 View Grants Info Organization Applicants

Assistance Listings Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions Who Can Apply:
FORMS-C Use for due dates after 9/24/2013. PKG00181224 Sep 16, 2013 Nov 18, 2015 View eRA Commons Help Desk Organization Applicants